Chest Implantation of Adjustable Gravitational Valves: An Easy, Safe, and Stable Alternative to Control Symptomatic Overdrainage in Shunted Children.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
02 2021
Historique:
received: 01 10 2020
revised: 31 10 2020
accepted: 02 11 2020
pubmed: 11 11 2020
medline: 22 6 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

Shunt overdrainage is a potential complication in pediatric hydrocephalus. The addition of adjustable gravitational units to previous shunt systems has been proposed as effective management for this problem. These devices have been traditionally implanted over the occipital bone. We propose chest implantation as an easier, safer, and more stable alternative in the pediatric population, especially in those cases with parieto-occipital shunts. This study comprises a retrospective analysis from a unicentric case series of pediatric patients affected by overdrainage and managed with adjustable gravitational valves implanted in the chest. The device implantation technique is described in detail and takes no more than 15 minutes. Thirty-seven patients met the criteria. The mean age of implantation was 9.62 years. The mean follow-up in the series was 38 months. The mean number of pressure adjustments was 2.48. The mean "deviation angle" of the device to the longitudinal body axis was 5.8°. The complications per year of shunt were <0.02 with no disconnection of the catheters in any case during follow-up. In our experience, chest implantation for adjustable gravitational devices was a suitable shunt modification in pediatric patients suffering from overdrainage.

Identifiants

pubmed: 33171320
pii: S1878-8750(20)32376-7
doi: 10.1016/j.wneu.2020.11.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-94

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Jorge Tirado-Caballero (J)

Service of Neurosurgery, University Hospital Virgen del Rocío, Seville, Spain; Group of Applied Neuroscience, Institute of Biomedicine of Seville, Seville, Spain; Neurosurgery Department, Hospital 12 de Octubre, Madrid, Spain. Electronic address: jtiradocaballero@gmail.com.

Mónica Rivero-Garvia (M)

Service of Neurosurgery, University Hospital Virgen del Rocío, Seville, Spain; Group of Applied Neuroscience, Institute of Biomedicine of Seville, Seville, Spain.

Gloria Moreno-Madueño (G)

Service of Neurosurgery, University Hospital Virgen del Rocío, Seville, Spain; Group of Applied Neuroscience, Institute of Biomedicine of Seville, Seville, Spain.

Emilio Gómez-González (E)

Group of Applied Neuroscience, Institute of Biomedicine of Seville, Seville, Spain; Group of Interdisciplinary Physics, Engineering School, Universidad de Sevilla, Seville, Spain.

Javier Marquez-Rivas (J)

Service of Neurosurgery, University Hospital Virgen del Rocío, Seville, Spain; Group of Applied Neuroscience, Institute of Biomedicine of Seville, Seville, Spain; Center for Advanced Neurology, Seville, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH